Alendronate
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
---- | ---- | ||
| - | Alendronate is | + | Alendronate is commonly known for its use in treatment and prevention of osteoporosis in postmenopausal women and men, but is also used to treat Paget's disease (disease that results in deformed and enlarged bones).<ref>http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000018/</ref> Alendronate belongs to the class of nitrogen-containing bisphosphonates, which are inorganic pyrophosphate analogues. |
| - | == History == | + | == History of Bisphosphonates == |
| + | |||
| + | ---- | ||
== Structure == | == Structure == | ||
| + | |||
| + | ---- | ||
== Target Protein == | == Target Protein == | ||
| + | |||
| + | ---- | ||
| Line 34: | Line 40: | ||
== Side affects of Drug == | == Side affects of Drug == | ||
| + | |||
| + | ---- | ||
| + | |||
| + | |||
| Line 40: | Line 50: | ||
| + | == References == | ||
| + | ---- | ||
<references/> | <references/> | ||
Revision as of 04:44, 11 March 2011
| Please do NOT make changes to this Sandbox. Sandboxes 30-60 are reserved for use by Biochemistry 410 & 412 at Messiah College taught by Dr. Hannah Tims during Fall 2012 and Spring 2013. |
Contents |
Alendronate (Fosamax®)
Alendronate is commonly known for its use in treatment and prevention of osteoporosis in postmenopausal women and men, but is also used to treat Paget's disease (disease that results in deformed and enlarged bones).[1] Alendronate belongs to the class of nitrogen-containing bisphosphonates, which are inorganic pyrophosphate analogues.
History of Bisphosphonates
Structure
Target Protein
|
Side affects of Drug
References
